Nutex Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hosseinion Warren, was filed 23 Mar 2026.
Who traded when
BuySaleSince the insiders bought
- +107.1%Entry US$99.49 · Close 22 Oct 2026 US$206.09
- +107.1%Entry US$99.49 · Close 22 Oct 2026 US$206.09
- +117.7%Entry US$94.66 · Close 22 Oct 2026 US$206.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 203 shares@ US$214.250.0033% mcap100.0% of flowCommon StockSEC:0002018971-26-000004:0
- 603 shares0Common StockSEC:0001303609-26-000004:0
- 603 shares0Common StockSEC:0001920511-26-000003:0
- 603 shares0Common StockSEC:0001922252-26-000003:0
- 603 shares0Common StockSEC:0002018971-26-000003:0
- 184,071 shares0Common StockSEC:0001919945-26-000002:0
- 150 shares@ US$93.555100.0% of flowCommon StockSEC:0001303609-26-000002:0Canonical exit: 18 Jun 2026 (T+90)
- 252 shares@ US$94.0723100.0% of flowCommon StockSEC:0001438327-26-000002:0Canonical exit: 17 Jun 2026 (T+90)
- 10 shares@ US$94.46100.0% of flowCommon StockSEC:0002018803-26-000002:0Canonical exit: 15 Jun 2026 (T+90)
- 79 shares@ US$88.8699100.0% of flowCommon StockSEC:0001919434-26-000002:0Canonical exit: 11 Jun 2026 (T+90)
- 776 shares@ US$86.2265.9% of flowCommon StockSEC:0001919434-26-000001:1
- 3,017 shares@ US$86.2218.8% of flowCommon StockSEC:0001919945-26-000001:1
- 82 shares@ US$86.2266.7% of flowCommon StockSEC:0002018803-26-000001:1
- 3,274 shares@ US$86.226.1% of flowCommon StockSEC:0001438327-26-000001:1
- 784 shares@ US$86.2275.0% of flowCommon StockSEC:0001486189-26-000003:1
- 769 shares@ US$86.2276.7% of flowCommon StockSEC:0001919832-26-000001:1
- 183 shares0Common StockSEC:0002018803-26-000001:0
- 2,667 shares0Common StockSEC:0001938758-26-000001:0
- 8,334 shares0Common StockSEC:0001919945-26-000001:0
- 2,084 shares0Common StockSEC:0001919832-26-000001:0
- 2,084 shares0Common StockSEC:0001919434-26-000001:0
- 6,293 shares0Common StockSEC:0001438327-26-000001:0
- 2,084 shares0Common StockSEC:0001486189-26-000003:0
- 750 shares@ US$136.709972.5% of flowCommon StockSEC:0001938758-25-000005:0Canonical exit: 23 Feb 2026 (T+90)
- 1,500 shares0Common StockSEC:0001486189-25-000017:1
25 of 121 declarations
About Nutex Health, Inc.
Nutex Health, Inc. is a record of executive purchases: 38 purchases for EUR 1,272,627 (median EUR 20,931) against 12 sales for EUR 2,532,025 (median EUR 221,688), which is 76% purchases by count. Thomas T. Vo, Chief Executive Officer, signs the three largest purchases: EUR 220,266 on May 25, 2023, EUR 207,231 on May 19, 2023 and EUR 94,600 on August 29, 2023. The filer has 26 filings, 14 purchases and no sale. From May 18 to June 15, 2023, seven filers bought for EUR 548,725. Across the full history, 16 purchase filings are classed as clustered. The 31 purchases with a stored 90-day result have a median of minus 31.3% (stored results, not a forecast).
The largest sales are by Warren Hosseinion, President, in September 2022: EUR 448,538 on September 2, EUR 425,489 on September 9 and EUR 320,312 on September 14. The filer has 16 filings, one purchase and 7 sales.
Read moreShow less
The record gathers 118 filings from 22 filers between September 9, 2020 and September 18, 2026, including 27 grants and 26 option exercises. The year 2022 peaks at 30 filings. Over the last twelve months: 24 filings, 5 purchases, one sale.
